Science VC
Science VC
✓

Balancing Risk Across Two Industries | From Scientist to VC to Founder | Building Trust Among Co-founders | Protecting IP & Unlocking Markets | Fundraising Insights from Brazil with Larissa de Farias Viana, CEO @ APEXzymes | Ep 5

00:57:22
Podcasts
RSS
Link

이 에피소드에 관해

Can a single innovation unlock multiple billion-dollar markets?

Larissa is the CEO of APEXzymes, a Brazilian biotech startup that produces cost-effective enzymes for sustainable industrial applications. During our conversation, Larissa shares her journey from chemical engineering to venture capital and entrepreneurship.

Topics in this episode

0:00 Intro
1:06 From Chemical Engineer to VC to Founder
4:56 Why Leave Venture Capital to Build a Startup?
6:38 How Self-Doubt Can Drive Innovation
8:25 Advice Before Starting APEXzymes
9:34 What Are Enzymes and Why Do They Matter?
12:19 APEXzymes’ Value Proposition
13:40 What Investors Miss About APEXzymes
17:13 Key Markets: Biofuels, Cattle Feed & More
19:48 How Enzymes Boost Productivity and Cut Methane
22:11 Early Commercial Traction
23:58 Communicating Traction to Investors
27:50 Turning Enzyme Strains Into Patentable Assets
32:43 Balancing Focus vs. Market Size
38:12 Lessons from Fundraising and Non-Dilutive Grants
43:33 What GRIDX Saw in APEXzymes
46:05 Building Trust With Co-Founders
49:00 Aligning Weekly Tasks With Long-Term Vision
55:22 What’s Next for APEXzymes?

Follow APEXzymes on LinkedIn https://www.linkedin.com/company/apexzymes/posts/?feedView=all
Connect with Larissa on LinkedIn https://www.linkedin.com/in/larissadefv/
Email Larissa larissa.viana@apexzymes.com

Connect with JP Orlov on LinkedIn https://www.linkedin.com/in/jp-orlov/
Follow Science VC on LinkedIn https://www.linkedin.com/company/science-vc
Follow Science VC on Instagram https://www.instagram.com/science.vc

Subscribe to Science VC on YouTube https://www.youtube.com/@ScienceVC
Subscribe to our Newsletter https://substack.com/@jporlov

Learn how WeArePalta can help your deeptech company communicate its science and impact https://www.wearepalta.com/

기술
기업 운영
비즈니스
영어
미국
API를 사용하여JSON에서 이 에피소드를 가져옵니다.

이 에피소드 내

이 태그 수정하기

전사 🔗

Are you the producer of this podcast? Add a podcast transcript
Need Audio-to-Text? Transcribe with Listen411 in Just 60 Seconds

과거 에피소드 검색

Science VC의 과거 에피소드를 검색하세요.
이 검색 창을 웹 사이트에 삽입

이 팟캐스트의 다른 에피소드

Disrupting Drug Discovery: Combining Quantum Electrochemistry and AI | Partnering with Oxford University | Why Second-Time Founders Have a Unique Edge | The Importance of Boldness and Patience with Diego Stone, CEO @ Qnity | Ep 2

Disrupting Drug Discovery: Combining Quantum Electrochemistry and AI | Partnering with Oxford University | Why Second-Time Founders Have a Unique Edge | The Importance of Boldness and Patience with Diego Stone, CEO @ Qnity | Ep 2

Investors don’t care how fancy your tech is.Diego is the CEO of Qnity, a pharmatech startup that uses quantum electrochemistry to develop devices for drug discovery and screening. In this episode, we discuss his lessons as a second-time founder and his insights on fundraising in the deeptech space.…
00:59:23
공유하기
저장하기
Picking the VCs You Approach | Protecting Your IP and Building Your Business Model | Creating Therapeutics for Animals Using Black Soldier Flies | Standing Out to Investors While Raising a Seed Round, with Gerardo Bluske, CBO @ ByBug | Ep 1

Picking the VCs You Approach | Protecting Your IP and Building Your Business Model | Creating Therapeutics for Animals Using Black Soldier Flies | Standing Out to Investors While Raising a Seed Round, with Gerardo Bluske, CBO @ ByBug | Ep 1

Why do founders have to be very picky about what VCs they approach?Gerardo Bluske is the Chief Business Officer of ByBug, a biotech startup that creates therapeutics for animals using black soldier flies. In this episode, Gerardo shares his insights about business development and fundraising.Topics…
00:56:05
공유하기
저장하기
The Business Case for Carbon Capture | A $200B Opportunity | Rethinking Industrial Supply Chains | Why You Need to Talk to Customers Early | Leveraging Non-Dilutive Capital with Alexander Ip, CEO @ CERT Systems | Ep 4

The Business Case for Carbon Capture | A $200B Opportunity | Rethinking Industrial Supply Chains | Why You Need to Talk to Customers Early | Leveraging Non-Dilutive Capital with Alexander Ip, CEO @ CERT Systems | Ep 4

Is it possible to transform carbon emissions into everyday products?Alex is the CEO of CERT Systems, a Canadian climatetech startup that converts CO2 emissions into high-value chemicals. In this episode, Alex shares his journey from the lab bench to raising non-dilutive capital. Topics in this epis…
00:58:04
공유하기
저장하기
Raising Capital in a Controversial Industry | Psychedelics & Mental Health | Building Investor Relationships | Showing Traction Before Regulatory Approval | Imposter Syndrome in LATAM Startups with Victoria Costa Paz, CEO @ EYWA | Ep 3

Raising Capital in a Controversial Industry | Psychedelics & Mental Health | Building Investor Relationships | Showing Traction Before Regulatory Approval | Imposter Syndrome in LATAM Startups with Victoria Costa Paz, CEO @ EYWA | Ep 3

There is a lot of stigma around psychedelics.Vicky is the CEO of EYWA, a biotech startup that produces molecules for mental health treatments. In this episode, we discussed the fundraising process for a startup working with psychedelics and the stigma surrounding the industry.Topics in this episode…
00:55:55
공유하기
저장하기
면책 조항: 이 페이지에 포함된 팟캐스트와 작품은 JP Orlov에서 가져온 것입니다. 이 팟캐스트는 소유자의 재산이며 Listen Notes, Inc.와 제휴하거나 보증하지 않습니다.
PROMOTED
The best Podcast API to search all podcasts and episodes. Trusted by 15,200+ companies and developers.
The best Podcast API to search all podcasts and episodes. Trusted by 15,200+ companies and developers.
PodcastAPI.com

추천
API를 사용하여 이 에피소드 가져오기